Acute Myelogenous Leukemia

Showing NaN - NaN of 60

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia Trial in France, United States (Inecalcitol, Placebo Oral Tablet)

Unknown status
  • Acute Myelogenous Leukemia
  • San Diego, California
  • +7 more
Jun 30, 2017

Refractory Leukemia, Acute Myelogenous Leukemia Trial in Worldwide (Panobinostat/LBH589)

Completed
  • Refractory Leukemia
  • Acute Myelogenous Leukemia
  • Chicago, Illinois
  • +39 more
Jan 8, 2017

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 16, 2016

Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

Terminated
  • Myelodysplastic and Myeloproliferative Disorders
  • +7 more
  • Houston, Texas
  • +1 more
Mar 29, 2016

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (IGN523)

Completed
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +5 more
Feb 22, 2016

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +7 more
Jun 4, 2015

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Houston (TH-302)

Completed
  • Acute Myelogenous Leukemia
  • +5 more
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
May 5, 2015

Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • BMS-936564 (Anti-CXCR4)
  • Birmingham, Alabama
  • +10 more
Mar 5, 2015

Acute Myelogenous Leukemia Trial in United States (cenersen, Idarubicin, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • La Jolla, California
  • +5 more
Sep 16, 2014

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)

Completed
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +19 more
Mar 17, 2014

Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • clofarabine (IV formulation)
  • +2 more
  • Scottsdale, Arizona
  • +56 more
Mar 17, 2014

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Birmingham, Alabama
  • +12 more
Mar 17, 2014

Acute Myelogenous Leukemia Trial in United States (clofarabine (IV formulation))

Completed
  • Acute Myelogenous Leukemia
  • clofarabine (IV formulation)
  • Los Angeles, California
  • +11 more
Mar 17, 2014

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab ozogamicin)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 3, 2013

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Revlimid)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 5, 2013

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab Ozogamicin)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 4, 2013

Acute Myelogenous Leukemia Trial in Houston (Decitabine)

Completed
  • Acute Myelogenous Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 25, 2013

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia Trial in Houston, Seattle (PR104)

Unknown status
  • Acute Myelogenous Leukemia
  • Acute Lymphocytic Leukemia
  • Houston, Texas
  • +1 more
Aug 30, 2012

Acute Myelogenous Leukemia, Chemo-induced Nausea and Vomiting Trial in Houston (Ondansetron, Palonosetron)

Completed
  • Acute Myelogenous Leukemia
  • Chemotherapy-induced Nausea and Vomiting
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (5-Azacytidine, Ara-C, Valproic Acid (VPA))

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Voriconazole, Liposomal amphotericin B)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Aug 1, 2012

Effectiveness of Protected Environment Rooms for AML and MDS

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
    • Houston, Texas
      UT MD Anderson Cancer Center
    Aug 1, 2012

    Quality of Life of Acute Myelogenous Leukemia or Myelodysplastic

    Completed
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Questionnaire
    • Neurocognitive Testing
    • Houston, Texas
      U.T.M.D. Anderson Cancer Center
    Jul 31, 2012

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Azacitidine, Ara-C)

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • Houston, Texas
      U.T.M.D. Anderson Cancer Center
    Jul 26, 2012

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia Trial in Houston (Mylotarg, Fludarabine,

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 31, 2012